BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29246902)

  • 21. Matriptase activation connects tissue factor-dependent coagulation initiation to epithelial proteolysis and signaling.
    Le Gall SM; Szabo R; Lee M; Kirchhofer D; Craik CS; Bugge TH; Camerer E
    Blood; 2016 Jun; 127(25):3260-9. PubMed ID: 27114461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
    Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
    Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling.
    Mandal SK; Pendurthi UR; Rao LV
    Blood; 2007 Jul; 110(1):161-70. PubMed ID: 17384202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
    Wiiger MT; Prydz H
    Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor.
    Poulsen LK; Jacobsen N; Sørensen BB; Bergenhem NC; Kelly JD; Foster DC; Thastrup O; Ezban M; Petersen LC
    J Biol Chem; 1998 Mar; 273(11):6228-32. PubMed ID: 9497347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells.
    Demetz G; Seitz I; Stein A; Steppich B; Groha P; Brandl R; Schömig A; Ott I
    Atherosclerosis; 2010 Oct; 212(2):466-71. PubMed ID: 20708733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex.
    Marutsuka K; Hatakeyama K; Sato Y; Yamashita A; Sumiyoshi A; Asada Y
    Thromb Res; 2002 Sep; 107(5):271-6. PubMed ID: 12479889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
    Carneiro-Lobo TC; Schaffner F; Disse J; Ostergaard H; Francischetti IM; Monteiro RQ; Ruf W
    J Thromb Haemost; 2012 Sep; 10(9):1849-58. PubMed ID: 22823596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue factor enhances protease-activated receptor-2-mediated factor VIIa cell proliferative properties.
    Fan L; Yotov WV; Zhu T; Esmailzadeh L; Joyal JS; Sennlaub F; Heveker N; Chemtob S; Rivard GE
    J Thromb Haemost; 2005 May; 3(5):1056-63. PubMed ID: 15869604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue factor in cancer progression and angiogenesis.
    Ruf W; Yokota N; Schaffner F
    Thromb Res; 2010 Apr; 125 Suppl 2(0 2):S36-8. PubMed ID: 20434002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural modulation of factor VIIa by full-length tissue factor (TF
    Prasad R; Sen P
    J Biomol Struct Dyn; 2018 Feb; 36(3):621-633. PubMed ID: 28150568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.
    Hu L; Xia L; Zhou H; Wu B; Mu Y; Wu Y; Yan J
    Tumour Biol; 2013 Oct; 34(5):2573-81. PubMed ID: 23616010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of tissue factor in cancer.
    Kasthuri RS; Taubman MB; Mackman N
    J Clin Oncol; 2009 Oct; 27(29):4834-8. PubMed ID: 19738116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity.
    Sorensen AB; Madsen JJ; Svensson LA; Pedersen AA; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
    J Biol Chem; 2016 Feb; 291(9):4671-83. PubMed ID: 26694616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
    Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
    Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential coagulation factor VIIa domain binding to tissue factor.
    Osterlund M; Persson E; Carlsson U; Freskgård PO; Svensson M
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1276-82. PubMed ID: 16236263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular dynamics simulations and functional characterization of the interactions of the PAR2 ectodomain with factor VIIa.
    Zhang Q; Petersen HH; Ostergaard H; Ruf W; Olson AJ
    Proteins; 2009 Nov; 77(3):559-69. PubMed ID: 19536895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.
    Hjortoe GM; Petersen LC; Albrektsen T; Sorensen BB; Norby PL; Mandal SK; Pendurthi UR; Rao LV
    Blood; 2004 Apr; 103(8):3029-37. PubMed ID: 15070680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.
    Chanakira A; Westmark PR; Ong IM; Sheehan JP
    Gynecol Oncol; 2017 Apr; 145(1):167-175. PubMed ID: 28148395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.